Investor Relations
“This was undoubtedly a very challenging year for the
business. Following margin pressure in the first half we took
decisive action to address the internal issues and mitigate the
external factors we faced. We are on track to restore margins
during this autumn to the levels previously enjoyed."
“The global healthcare market has proved resilient during the
economic downturn and demand for our services generally remains
strong driven by demographic trends, regulatory pressures and
government spending commitments. We opened new sites in the
period and are close to completing new facilities in the UK, Europe
and, most importantly, China. These new sites will drive
organic growth rates in the coming years."
“Following a period characterised by acquisitions and
significant investment in new facilities, the immediate future will
focus on realising the benefits of these investments, in particular
Synergy’s strong cash generation which will be used to reduce net
debt. The strategy remains to enter new health-related
markets, expand into new European territories and develop a
significant presence in the fast-growing Asian markets. We
expect the imminent opening of our first facility in China to mark
the start of a period of strong growth from this region and we are
confident that Synergy will continue to prosper in the year
ahead.”
Dr Richard Steeves, Chief Executive
Excerpt from the Preliminary Results for the Year Ended 29 March
2009.
Check Synergy Health's latest share price on the
London Stock Exchange website.